Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 19OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 9485Neoplasms 6599Prostatic Neoplasms 4404Colorectal Neoplasms 3979Lung Neoplasms 3647Carcinoma, Non-Small-Cell Lung 3587Pancreatic Neoplasms 2480Carcinoma, Hepatocellular 2416Leukemia, Myeloid, Acute 2266Multiple Myeloma 2123Stomach Neoplasms 2109Neoplasm Metastasis 1913Head and Neck Neoplasms 1873Ovarian Neoplasms 1778Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1731Brain Neoplasms 1706Rectal Neoplasms 1676Melanoma 1657Colonic Neoplasms 1629Uterine Cervical Neoplasms 1501Leukemia 1500Recurrence 1486Esophageal Neoplasms 1312Glioblastoma 1310Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1080Lymphoma, Follicular 1069

Interventions

nilotinib 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Giant Cell Tumor of Tendon Sheath × Clear all
NCT01207492 2026-02-20

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Dana-Farber Cancer Institute

Phase 2 Completed
17 enrolled 8 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT07315841 2026-01-05

ICG-TGCT

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Phase 4 Recruiting
40 enrolled

Giant Cell Tumor of Tendon Sheath

Data powered by HemOnc (CC BY 4.0) Colophon âš¡